– Analysis Comparing Real-World and Clinical Trial Data Show Yescarta® Has Higher Manufacturing Success Rates and Improved T-Cell Performance, Respectively, in Second-Line vs. Third-Line+ Treatment of...
Source Link– Analysis Comparing Real-World and Clinical Trial Data Show Yescarta® Has Higher Manufacturing Success Rates and Improved T-Cell Performance, Respectively, in Second-Line vs. Third-Line+ Treatment of...
Source Link
Comments